Skip to main content
Top
Published in: BMC Ophthalmology 1/2018

Open Access 01-09-2018 | Case report

A long history of dense deposit disease

Authors: Alan Cunningham, Ajay Kotagiri

Published in: BMC Ophthalmology | Special Issue 1/2018

Login to get access

Abstract

Background

Dense Deposit Disease is a rare condition affecting the Bruch’s membrane and the glomerular basement membrane. We report the progression of the ocular manifestations over a 30 year follow up period, longer than any previous report.

Case presentation

A 44 year old male presented with pigmentary changes at the macula noted by his optician. Best corrected visual acuity at presentation was good in both eyes. Fundoscopy showed pigmentary changes and drusen, and investigation using intravenous fundus fluorescein angiography did not demonstrate any choroidal neovascular membrane. The patient subsequently developed renal failure and received a dual renal transplant. The transplanted kidneys also failed over the coming year. The patient’s vision gradually deteriorated and comparison between the images in 2010 and 1985 demonstrated a clear progression of the macula changes. Optical coherence tomography showed multiple subretinal hyper reflective drusenoid deposits. These deposits were also noted to be autofluorescent on blue auto-fluorescence. The young age at presentation of drusen, combined with the history of recurrent kidney failure and progression of subretinal deposits led to a diagnosis of dense deposit disease.

Conclusions

Dense deposit disease is a rare condition affecting Bruch’s membrane, but should be considered in the differential diagnosis of any patient under the age of 50 years presenting with drusen.
Literature
1.
go back to reference D’souza Y, Short CD, McLeod D, Bonshek RE. Long-term follow-up of drusen-like lesions in patients with type II mesangiocapillary glomerulonephritis. BrJOphthalmol. 2008;92:950–3. D’souza Y, Short CD, McLeod D, Bonshek RE. Long-term follow-up of drusen-like lesions in patients with type II mesangiocapillary glomerulonephritis. BrJOphthalmol. 2008;92:950–3.
2.
go back to reference D’Souza YB, Short CD. The eye--a window on the kidney. Nephrol Dial Transplant. 2009;24:3582–4.CrossRefPubMed D’Souza YB, Short CD. The eye--a window on the kidney. Nephrol Dial Transplant. 2009;24:3582–4.CrossRefPubMed
3.
go back to reference Duvall-Young J, MacDonald MK, McKechnie NM. Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report. Br J Ophthalmol. 1989;73:297–302.CrossRefPubMedPubMedCentral Duvall-Young J, MacDonald MK, McKechnie NM. Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report. Br J Ophthalmol. 1989;73:297–302.CrossRefPubMedPubMedCentral
5.
go back to reference Appel G, Cook H, Hageman G, Jennette J, Kashgarian M, Kirschfink M, et al. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol. 2005;16:1392–403.CrossRefPubMed Appel G, Cook H, Hageman G, Jennette J, Kashgarian M, Kirschfink M, et al. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol. 2005;16:1392–403.CrossRefPubMed
6.
go back to reference Nasr SH, Valeri AM, Appel GB, Sherwinter J, Stokes MB, Said SM, et al. Dense deposit disease: Clinicopathologic study of 32 pediatric and adult patients. Clin J Am Soc Nephrol. 2009;4:22–32.CrossRefPubMedPubMedCentral Nasr SH, Valeri AM, Appel GB, Sherwinter J, Stokes MB, Said SM, et al. Dense deposit disease: Clinicopathologic study of 32 pediatric and adult patients. Clin J Am Soc Nephrol. 2009;4:22–32.CrossRefPubMedPubMedCentral
8.
go back to reference Savige J, Amos L, Ierino F, Mack HG, Symons RCA, Hughes P, et al. Retinal disease in the C3 glomerulopathies and the risk of impaired vision. Ophthalmic Genet. 2016;37(4):369–76.CrossRefPubMed Savige J, Amos L, Ierino F, Mack HG, Symons RCA, Hughes P, et al. Retinal disease in the C3 glomerulopathies and the risk of impaired vision. Ophthalmic Genet. 2016;37(4):369–76.CrossRefPubMed
9.
go back to reference Boon C, van de Kar N, Klevering B, Keunen J, Cremers F, Klaver C, et al. The spectrum of phenotypes caused by variants in the CFH gene. Mol Immunol. 2009;46(8–9):1573–94.CrossRefPubMed Boon C, van de Kar N, Klevering B, Keunen J, Cremers F, Klaver C, et al. The spectrum of phenotypes caused by variants in the CFH gene. Mol Immunol. 2009;46(8–9):1573–94.CrossRefPubMed
10.
go back to reference Gupta N, Wakefield DN, Clapp WL, Garin EH. Use of C4d as a diagnostic tool to classify membranoproliferative glomerulonephritis. Nefrologia. 2017;7:78–86.CrossRef Gupta N, Wakefield DN, Clapp WL, Garin EH. Use of C4d as a diagnostic tool to classify membranoproliferative glomerulonephritis. Nefrologia. 2017;7:78–86.CrossRef
11.
go back to reference Gehrs KM, Jackson JR, Brown EN, Allikmets R, Hageman GS. Complement, age-related macular degeneration and a vision of the future. Arch Ophthalmol. 2010;128(3):349–58.CrossRefPubMedPubMedCentral Gehrs KM, Jackson JR, Brown EN, Allikmets R, Hageman GS. Complement, age-related macular degeneration and a vision of the future. Arch Ophthalmol. 2010;128(3):349–58.CrossRefPubMedPubMedCentral
12.
go back to reference Wang H, Han X, Wittchen ES, Hartnett ME. TNF-alpha mediates choroidal neovascularization by upregulating VEGF expression in RPE through ROS-dependent beta-catenin activation. Mol Vis. 2016;22(November 2015):116–28.PubMedPubMedCentral Wang H, Han X, Wittchen ES, Hartnett ME. TNF-alpha mediates choroidal neovascularization by upregulating VEGF expression in RPE through ROS-dependent beta-catenin activation. Mol Vis. 2016;22(November 2015):116–28.PubMedPubMedCentral
15.
go back to reference Boon CJF, van den Born LI, Visser L, Keunen JEE, Bergen AAB, Booij JC, et al. Autosomal recessive bestrophinopathy: differential diagnosis and treatment options. Ophthalmology Elsevier. 2013;120:809–20.CrossRef Boon CJF, van den Born LI, Visser L, Keunen JEE, Bergen AAB, Booij JC, et al. Autosomal recessive bestrophinopathy: differential diagnosis and treatment options. Ophthalmology Elsevier. 2013;120:809–20.CrossRef
16.
go back to reference Abouzeid H, Wolfensberger TJ, Schorderet DF, Munier FL. Unilateral macular oedema in Zermatt and Stargardt macular dystrophies. Br J Ophthalmol. 2009;93:1376–1377-1408.CrossRefPubMed Abouzeid H, Wolfensberger TJ, Schorderet DF, Munier FL. Unilateral macular oedema in Zermatt and Stargardt macular dystrophies. Br J Ophthalmol. 2009;93:1376–1377-1408.CrossRefPubMed
17.
go back to reference Klevering BJ, van Driel M, van Hogerwou AJM, van De Pol DJR, Deutman AF, Pinckers AJLG, et al. Central areolar choroidal dystrophy associated with dominantly inherited drusen. Br J Ophthalmol. 2002;86:91–6.CrossRefPubMedPubMedCentral Klevering BJ, van Driel M, van Hogerwou AJM, van De Pol DJR, Deutman AF, Pinckers AJLG, et al. Central areolar choroidal dystrophy associated with dominantly inherited drusen. Br J Ophthalmol. 2002;86:91–6.CrossRefPubMedPubMedCentral
18.
go back to reference Jansen J, Delaere L, Spielberg L, Leys A. Long-term fundus changes in acquired partial lipodystrophy. BMJ Case Rep. 2013:2–4. Jansen J, Delaere L, Spielberg L, Leys A. Long-term fundus changes in acquired partial lipodystrophy. BMJ Case Rep. 2013:2–4.
Metadata
Title
A long history of dense deposit disease
Authors
Alan Cunningham
Ajay Kotagiri
Publication date
01-09-2018
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue Special Issue 1/2018
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-018-0853-8

Other articles of this Special Issue 1/2018

BMC Ophthalmology 1/2018 Go to the issue